These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27138298)

  • 1. Novel Salted Anionic-Cationic Polymethacrylate Polymer Blends for Sustained Release of Acidic and Basic Drugs.
    Obeidat WM; Qasim D; Nokhodchi A; Al-Jabery A; Sallam AS
    Curr Drug Deliv; 2017; 14(1):109-122. PubMed ID: 27138298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and Evaluation of Ternary Polymeric Blends for Controlled Release Matrices Containing Weakly Basic Model Drug.
    Obeidat WM; Gharaibeh SF; Jaradat AA; Abualsuod O
    Curr Drug Deliv; 2021; 18(1):54-64. PubMed ID: 32735522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Once Daily Controlled-release Ibuprofen Matrix Tablets Prepared using Eudragit
    Obeidat WM; Al-Natour MA
    Curr Drug Deliv; 2022; 19(1):74-85. PubMed ID: 34176461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained release tablets containing soluble polymethacrylates: comparison with tableted polymethacrylate IPEC polymers.
    Obeidat WM; Abuznait AH; Sallam AS
    AAPS PharmSciTech; 2010 Mar; 11(1):54-63. PubMed ID: 20054671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel combination of anionic and cationic polymethacrylate polymers for sustained release tablet preparation.
    Obeidat WM; Abu Znait AH; Sallam AS
    Drug Dev Ind Pharm; 2008 Jun; 34(6):650-60. PubMed ID: 18568916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermal treating of acrylic matrices as a tool for controlling drug release.
    Hasanzadeh D; Ghaffari S; Monajjemzadeh F; Al-Hallak MH; Soltani G; Azarmi S
    Chem Pharm Bull (Tokyo); 2009 Dec; 57(12):1356-62. PubMed ID: 19952444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of controlled release matrices based on novel seaweed interpolyelectrolyte complexes.
    Prado HJ; Matulewicz MC; Bonelli PR; Cukierman AL
    Int J Pharm; 2012 Jun; 429(1-2):12-21. PubMed ID: 22433798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation studies on ibuprofen sodium-cationic dextran conjugate: effect on tableting and dissolution characteristics of ibuprofen.
    Abioye AO; Kola-Mustapha A
    Drug Dev Ind Pharm; 2016 Jan; 42(1):39-59. PubMed ID: 25826253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and in vitro evaluation of directly compressed controlled release tablets designed from the Co-precipitates.
    Khan KA; Khan GM; Jan SU; Rehman A; Mehsud S
    Pak J Pharm Sci; 2018 Mar; 31(2):455-461. PubMed ID: 29618434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and in vitro analysis of floating matrix tablets of metronidazole using Brachystegia eurycoma gum.
    Ovenseri AC; Clifford O; Uwumagbe UM
    Pak J Pharm Sci; 2018 Jul; 31(4):1243-1249. PubMed ID: 30033407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation development and investigation of ibuprofen controlled release tablets with hydrophilic polymers and the effect of co-excipients on drug release patterns.
    Jan SU; Khan GM; Hussain I
    Pak J Pharm Sci; 2012 Oct; 25(4):751-6. PubMed ID: 23009990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Floating and sustained-release characteristics of effervescent tablets prepared with a mixed matrix of Eudragit L-100-55 and Eudragit E PO.
    Bani-Jaber AK; Alkawareek MY; Al-Gousous JJ; Abu Helwa AY
    Chem Pharm Bull (Tokyo); 2011; 59(2):155-60. PubMed ID: 21297292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanical properties of excipients do not affect polymer matrix formation.
    Chatterjee L; Rades T; Tucker IG
    Int J Pharm; 2010 Jan; 384(1-2):87-92. PubMed ID: 19819317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
    Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
    Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled-release matrix tablets of ibuprofen using cellulose ethers and carrageenans: effect of formulation factors on dissolution rates.
    Nerurkar J; Jun HW; Price JC; Park MO
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):56-68. PubMed ID: 15893919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of controlled release ibuprofen matrix tablets by direct compression technique.
    Patel N; Madan P; Lin S
    Pharm Dev Technol; 2011 Feb; 16(1):1-11. PubMed ID: 20491616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and in vitro/in vivo evaluation of sustained-release floating tablets of itopride hydrochloride.
    Ahmed SM; Ahmed Ali A; Ali AM; Hassan OA
    Drug Des Devel Ther; 2016; 10():4061-4071. PubMed ID: 28008229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends.
    Rujivipat S; Bodmeier R
    Eur J Pharm Biopharm; 2010 Nov; 76(3):486-92. PubMed ID: 20868750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.